Skip to main content

6-K

Definium Therapeutics, Inc. (DFTX)

6-K 2021-12-07 For: 2021-12-06
View Original
Added on April 12, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TORULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2021

Commission File Number:  001-40360

MIND MEDICINE (MINDMED) INC.

(Nameof registrant)

One World Trade Center

Suite 8500

New York, New York 10007

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

¨ Form 20-F x Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K

See Exhibit Index hereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MIND MEDICINE (MINDMED) INC.
(Registrant)
Date:  December 7, 2021 By: /s/ Robert Barrow
Name: Robert Barrow
Title: Chief Executive Officer

Form 6-K Exhibit Index

Exhibit Number Document Description
99.1 Notice, dated December 6, 2021.
99.2 Letter from former auditor, dated December 6, 2021.
99.3 Letter from successor auditor, dated December 6, 2021

Exhibit 99.1


NOTICE OF CHANGE OF AUDITOR


PURSUANT TO NATIONALINSTRUMENT 51-102OF THE CANADIAN SECURITIES ADMINISTRATORS

TO: ONTARIO SECURITIES COMMISSION
**** BRITISH COLUMBIA SECURITIES COMMISSION ALBERTA SECURITIES COMMISSION
**** THE MANITOBA SECURITIES COMMISSION
**** FINANCIAL AND CONSUMER SERVICES COMMISSION (NEW BRUNSWICK) NOVA SCOTIA SECURITIES COMMISSION
**** OFFICE OF THE SUPERINTENDENT OF SECURITIES, SERVICE NEWFOUNDLAND & LABRADOR
**** THE OFFICE OF THE SUPERINTENDENT SECURITIES (PRINCE EDWARD ISLAND)
**** FINANCIAL AND CONSUMER AFFAIRS AUTHORITY OF SASKATCHEWAN AUTORITÉ DES MARCHÉS FINANCIERS
**** REGISTRAR OF SECURITIES, GOVERNMENT OF YUKON TERRITORY SECURITIES REGISTRY, GOVERNMENT OF
**** THE NORTHWEST TERRITORIES
**** REGISTRAR OF SECURITIES, NUNAVUT
AND TO: RSM CANADA LLP
AND TO: ERNST & YOUNG LLP

We hereby provide notice pursuant to Section 4.11 of National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”) in respect of the resignation of RSM Canada LLP as the auditor of Mind Medicine (MindMed) Inc. (the “Company”) and the appointment of Ernst & Young LLP as auditor of the Company.

We confirm that:

1. On December 1, 2021 (the “Effective Date”), RSM Canada LLP (the<br> “Former Auditor”) resigned as auditor of the Company at the request of the Company.
2. The Company’s audit committee and board of directors considered and approved<br>the resignation of the Former Auditor as auditor of the Company and the appointment of Ernst & Young LLP (the “SuccessorAuditor”) as successor auditor effective as of the Effective Date.
--- ---
3. There were no reservations in the Former Auditor’s reports<br>on the Company’s annual consolidated financial statements for the period commencing at the beginning of the Company’s two<br>most recently completed financial years and ending on the Effective Date.
--- ---
4. In the opinion of the Company, there have been no “reportable events”<br>(as such term is defined in NI 51-102) involving the Company and the Former Auditor.
--- ---
DATED as of this 6th day of December, 2021.
---
MIND MEDICINE (MINDMED) INC.
/s/ David Guebert
Name: David Guebert
Title: Chief Financial Officer

Exhibit99.2


RSM CanadaLLP


11 King St W

Suite 700, Box 27
December 6, 2021 Toronto, ON M5H 4C7
Ontario Securities Commission T +1416 480 0160
British Columbia Securities Commission F +1 416 480 2646
Alberta Securities Commission
The Manitoba Securities Commission www.rsmcanada.com

Financial and Consumer Services Commission (New Brunswick)

Nova Scotia Securities Commission

Office of the Superintendent of Securities, Service Newfoundland & Labrador

The Office of the Superintendent Securities (Prince Edward Island)

Financial and Consumer Affairs Authority of Saskatchewan

Autorite des marches financiers

Registrar of Securities, Government of Yukon Territory

Securities Registry, Government of the Northwest Territories

Registries of Securities, Nunavut

Dear Sirs/Mesdames:

Re: MindMedicine (MindMed) Inc. (the "Company")<br><br> Notice of Change of Auditor


We acknowledge receipt of a Notice of Change of Auditor (the**"Notice")** dated December 6, 2021 delivered to us by the Company in respect of the change of auditor of the Company as it relates to RSM Canada LLP.

Pursuant to National Instrument 51-102 of the Canadian Securities Administrators, please accept this letter as confirmation that we have reviewed the Notice and, based on our knowledge as at the time of receipt of the Notice, we agree with each of the statements therein.

Yours truly,

RSM Canada LLP

/s/ RSM Canada LLP


Chartered Professional Accountants

Licensed Public Accountants

THE POWER OF BEING UNDERSTOOD

AUDIT I TAX I CONSULTING

Exhibit 99.3

Ernst & Young LLP <br> Chartered Accountants<br> 100 Adelaide St W <br> M5H 1S3 Tel: +1 416 864 1234<br> Fax: +1 416 864 1174<br> ey.com/ca

December 6, 2021

Ontario Securities Commission

British Columbia Securities Commission

Alberta Securities Commission

Financial and Consumer Affairs Authority of Saskatchewan

The Manitoba Securities Commission

New Brunswick Financial and Consumer Services Commission

Nova Scotia Securities Commission

Office of the Superintendent of Securities, Service Newfoundland & Labrador

Office of the Superintendent of Securities, Prince Edward Island

Autorité des marchés financiers

Registrar of Securities, Government of Yukon Territory

Securities Registry, Government of the Northwest Territories

Registries of Securities, Nunavut

Dear Sirs/Mesdames:

Re: Mind Medicine (MindMed) Inc.
Change of Auditor Notice dated December 6, 2021

Pursuant to National Instrument 51-102 (Part 4.11), we have read the above-noted Change of Auditor Notice and confirm our agreement with the information contained in the Notice pertaining to our firm.

Yours sincerely,

/s/ Ernst & Young LLP

Cc: The Board of Directors, Mind Medicine (MindMed) Inc.

1